» Articles » PMID: 12974476

Co-stimulatory Members of the TNFR Family: Keys to Effective T-cell Immunity?

Overview
Journal Nat Rev Immunol
Date 2003 Sep 17
PMID 12974476
Citations 345
Authors
Affiliations
Soon will be listed here.
Abstract

Interactions between co-stimulatory ligands and their receptors are crucial for the activation of T cells, the prevention of tolerance and the development of T-cell immunity. It is now evident that members of the immunoglobulin-like CD28-B7 co-stimulatory family cannot fully account for an effective long-lasting T-cell response or the generation of memory T cells. Several members of the tumour-necrosis factor receptor (TNFR) superfamily--OX40, 4-1BB, CD27, CD30 and HVEM (herpes-virus entry mediator)--are poised to deliver co-stimulatory signals both early and late after encounter with antigen. The roles of these molecules in initiating and sustaining the T-cell response and in promoting long-lived immunity are discussed.

Citing Articles

MD Simulation Reveals a Trimerization-Enhanced Interaction of CD137L with CD137.

Wang H, Wu J, Fang Y, Li Q Int J Mol Sci. 2025; 26(5).

PMID: 40076530 PMC: 11899465. DOI: 10.3390/ijms26051903.


MiR-125b-5p ameliorates ox-LDL-induced vascular endothelial cell dysfunction by negatively regulating TNFSF4/TLR4/NF-κB signaling.

He W, Zhao L, Wang P, Ren M, Han Y BMC Biotechnol. 2025; 25(1):11.

PMID: 39856662 PMC: 11760099. DOI: 10.1186/s12896-025-00944-y.


From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy.

Pinto E, Lione L, Compagnone M, Paccagnella M, Salvatori E, Greco M J Transl Med. 2025; 23(1):10.

PMID: 39755643 PMC: 11700462. DOI: 10.1186/s12967-024-06052-3.


Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer.

Croft M, Salek-Ardakani S, Ware C Nat Rev Drug Discov. 2024; 23(12):939-961.

PMID: 39448880 DOI: 10.1038/s41573-024-01053-9.


Induction of an immune response by a nonreplicating adenoviruses-based formulation versus a commercial pseudo-SARS-CoV-2 vaccine.

Baran J, Kuryk L, Garofalo M, Pancer K, Wieczorek M, Kazek M BioTechnologia (Pozn). 2024; 105(3):263-272.

PMID: 39439719 PMC: 11492889. DOI: 10.5114/bta.2024.141805.